Literature DB >> 16723090

PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression.

Kai Sun1, Qian Wang, Xiao-Hui Huang.   

Abstract

AIM: To investigate the effect of peroxisome proliferator-activated receptor gamma (PPAR gamma ) activation on the growth of rat hepatic stellate cells (HSC) and transforming growth factor beta (TGF-beta)-induced connective tissue growth factor (CTGF) expression.
METHODS: After being treated with various amounts of the PPAR gamma natural ligand 15-deoxy-delta12,14-prostaglandin J(2) (15-d-PGJ(2)) or synthetic ligand GW7845, the status of HSC proliferation and apoptosis were detected by MTT assay and flow cytometry. Furthermore, HSC were treated with PPAR gamma -specific antagonist GW9662 prior to the addition of 15-d-PG J(2) or GW7845 and were subsequently stimulated with TGF- beta1. The mRNA and protein levels of CTGF expression were detected by semi-quantitative RT-PCR and Western blotting analysis. Morphological changes in the HSC were observed by electron microscopy.
RESULTS: 15-d-PGJ(2) and GW7845 markedly inhibited HSC proliferation and induced cell apoptosis in a dose-dependent manner. Furthermore, PPAR gamma ligands significantly suppressed TGF-beta1-induced CTGF expression (at both transcriptional and post-transcriptional levels) in HSC, and the inhibitory effect was dramatically, if not completely, abolished by pretreatment with GW9662, suggesting that the inhibition was indeed mediated by PPAR gamma. Moreover, morphological observation revealed that PPAR gamma activation caused obvious changes of HSC from activated to quiescent phenotype.
CONCLUSION: The PPAR gamma ligand has a potent inhibitory effect on the growth of HSC and TGF-beta1-induced CTGF expression, which makes it a potential antifibrotic candidate for the treatment and prevention of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723090     DOI: 10.1111/j.1745-7254.2006.00299.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  26 in total

1.  MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.

Authors:  Kai Sun; Wei Wang; Jun-jie Zeng; Cheng-tang Wu; Shang-tong Lei; Guo-xin Li
Journal:  Acta Pharmacol Sin       Date:  2011-01-31       Impact factor: 6.150

2.  PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.

Authors:  Caiyan Zhao; Wei Chen; Liu Yang; Lihong Chen; Stephen A Stimpson; Anna Mae Diehl
Journal:  Biochem Biophys Res Commun       Date:  2006-09-22       Impact factor: 3.575

3.  Losartan Rescues Inflammation-related Mucociliary Dysfunction in Relevant Models of Cystic Fibrosis.

Authors:  Michael D Kim; Nathalie Baumlin; Makoto Yoshida; Deepika Polineni; Sebastian F Salathe; Joseph K David; Charles A Peloquin; Adam Wanner; John S Dennis; Juliette Sailland; Philip Whitney; Frank T Horrigan; Juan R Sabater; William M Abraham; Matthias Salathe
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

Review 4.  Adiponectin, a key adipokine in obesity related liver diseases.

Authors:  Christa Buechler; Josef Wanninger; Markus Neumeier
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 5.  Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo.

Authors:  Mohsen Mazidi; Ehsan Karimi; Mohsen Meydani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  World J Methodol       Date:  2016-03-26

6.  Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.

Authors:  Yan Liu; Heng Liu; Christoph Meyer; Jun Li; Silvio Nadalin; Alfred Königsrainer; Honglei Weng; Steven Dooley; Peter ten Dijke
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

7.  Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB.

Authors:  Hui Yang; Long-Feng Zhao; Zhong-Fu Zhao; Yan Wang; Jing-Jing Zhao; Li Zhang
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

Review 8.  Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.

Authors:  Feng Zhang; Desong Kong; Yin Lu; Shizhong Zheng
Journal:  Cell Mol Life Sci       Date:  2012-06-15       Impact factor: 9.261

9.  Joint contracture is reduced by intra-articular implantation of rosiglitazone-loaded hydrogels in a rabbit model of arthrofibrosis.

Authors:  Diren Arsoy; Christopher G Salib; William H Trousdale; Meagan E Tibbo; Afton K Limberg; Anthony Viste; Eric A Lewallen; Nicolas Reina; Michael J Yaszemski; Daniel J Berry; Andre J van Wijnen; Mark E Morrey; Joaquin Sanchez-Sotelo; Matthew P Abdel
Journal:  J Orthop Res       Date:  2018-07-13       Impact factor: 3.494

Review 10.  Senescence in hepatic stellate cells as a mechanism of liver fibrosis reversal: a putative synergy between retinoic acid and PPAR-gamma signalings.

Authors:  Concetta Panebianco; Jude A Oben; Manlio Vinciguerra; Valerio Pazienza
Journal:  Clin Exp Med       Date:  2016-09-21       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.